Aristotle University Of Thessaloniki (AUTH)
Ru(II) polypyridyl complexes functionalized with rhodamine and estrogen derivatives for light-activated cytotoxicity
Abstract
dc:descriptionPhotodynamic therapy (PDT) constitutes a promising approach for cancer treatment, however, several challenges limit its broader application, including insufficient selectivity towards cancer cells, limited tissue penetration of short-wavelength light and reduced efficacy of oxygen-dependent pathways in hypoxic tumour environments. Transition-metal complexes, particularly Ru(II) polypyridyl complexes, represent attractive platforms for addressing these limitations because their photophysical, photochemical and biological properties can be systematically modulated through ligand design. The present thesis focuses on the rational design, synthesis and investigation of functionalized Ru(II) polypyridyl complexes for cancer phototherapy, with particular emphasis on the relationship between ligand functionalization, excited-state energetics and photochemical reactivity. Three interconnected research projects were undertaken to explore how modifications of the ligand environment can address the principal limitations of PDT. Overall, the three research projects undertaken during this doctoral thesis are united by a common objective: to understand how ligand functionalization can be employed to tailor the phototherapeutic properties of Ru(II) polypyridyl complexes according to the intended application. By examining strategies for improving cancer-cell selectivity, extending the absorption towards the red region, introducing alternative photocatalytic pathways and controlling photoactivated ligand dissociation, this thesis seeks to establish a broader understanding of the relationship between molecular design, excited-state energetics and photochemical function. Particular attention is given to determining whether modifications intended to improve one phototherapeutic property, such as cellular targeting or long-wavelength absorption, can simultaneously preserve the excited-state characteristics required for the desired photochemical mechanism. Ultimately, this approach aims to contribute to the rational development of next-generation Ru(II)-based phototherapeutic agents with improved selectivity, activation at therapeutically relevant wavelengths and photochemical properties tailored to their intended mechanism of action.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsoni, Sofia-Alexandra
- Τσώνη, Σοφία-Αλεξάνδρα
Subjects
dc:subject × 12Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/63102